Clinical Efficacy and Molecular Biomarkers in a Phase II Study of Tucidinostat Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Ying Fang, State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; National Research Center